Combined synopsis and solicitation, 8(a) sole source
Preclinical Validation of Behavioral Economic Methods for Abuse Potential Assessment
NOI135740
Food and Drug Administration, FDA Office of Acq Grant SVCS. All Other Professional, Scientific, and Technical Services.
Response deadline
August 4, 2026 at 10:00 AM EDT
Closed 89 days ago. Posted July 28, 2026. Scheduled to archive August 19, 2026.
Get the next one like this from Food and Drug Administration by email, the day it is posted.Find my opportunities
This one closed in 2026
26 like it are open now in all other professional, scientific, and technical services
- Water Resources Analytical and Professional Support Services - Multiple Award Task Order Contract (MATOC)
Department of the Army, W4LD USA Hecsa
Sources soughtNAICS 541990Location not publishedW912HQ27S0006Closes in 5 daysNov 6 - U.S. Embassy Mexico—International Narcotics & Law Enforcement Affairs (INL Mexico) CONOCER Criminal Analyst Certification Services
Department of State, Acquisitions - Aqm Momentum
SolicitationNAICS 541990Outside the US19AQMM26Q0469Closes in 5 daysNov 6 - Quality Assurance Services - Civil Works, Interagency and International Services (IIS), and Military Construction Projects in Puerto Rico and U.S. Virgin Islands
Department of the Army, W2SR Endist Caribbean
SolicitationSmall businessNAICS 541990Several statesW51DQV27RA002Closes in 12 daysNov 13
All 26 open in all other professional, scientific, and technical services
Description
As published on SAM.gov.
Preclinical Validation of Behavioral Economic Methods for Abuse Potential Assessment
Attachments
Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.
- Notice of Intent.pdf121 KB, July 28, 2026
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
July 28, 2026
Combined synopsis and solicitation
Due August 4, 2026 at 10:00 AM EDT. SAM.gov, notice 95c90e5cc72c48299894e38ae7f0c31f
1 revisions on SAM
- July 28, 2026: publish, combined synopsis and solicitation
Points of contact
- Telisha Wilsontelisha.wilson@fda.hhs.gov2404027572